Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropiclobet for upper extremity surgery nerve block
NCT07131657Phase 2Completed
- Sponsor
- Pharmafina
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine + betamethasone + clonidine, sponsored by Pharmafina. Started Sep 2025; status: completed.
02
Drugs
ropivacaine + betamethasone + clonidine
Beyond the preview
Go deeper on NCT07131657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07131657.